Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.70 -0.94% 74.00 73.50 74.00 74.40 73.20 74.40 250,467 16:35:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 135.6 32.9 5.1 14.5 393

Alliance Pharma PLC Notification of Major Holdings

25/09/2020 2:46pm

UK Regulatory (RNS & others)


TIDMAPH

RNS Number : 1893A

Alliance Pharma PLC

25 September 2020

TR-1: S tandard form for notification of major holdings

 
 
 
 1a. Identity of the issuer or the                                          Alliance Pharma PLC 
  underlying issuer of existing shares 
  to which voting rights are attached 
  : 
                                                         --------------------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                ------------------ 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                             X 
                                                                                                ------------------ 
 An acquisition or disposal of financial instruments 
                                                                                                ------------------ 
 An event changing the breakdown of voting rights 
                                                                                                ------------------ 
 Other (please specify): 
                                                                                                ------------------ 
 3. Details of person subject to the notification obligation 
 Name                                                     Kempen Capital Management N.V. 
 City and country of registered office                    Amsterdam, The Netherlands 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.) 
 Name 
                                                         --------------------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                         --------------------------------------------------------- 
 5. Date on which the threshold was                       23 September 2020 
  crossed or reached : 
                                                         --------------------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):           23 September 2020 
                                                         --------------------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                                      % of voting         % of voting rights    Total of both    Total number 
                                     rights attached      through financial      in % (8.A +      of voting rights 
                                    to shares (total         instruments             8.B)         of issuer 
                                        of 8. A)            (total of 8.B 
                                                              1 + 8.B 2) 
                                -----------------------  -------------------  ----------------  ------------------ 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached                             5.01%                                      5.01%           531,236,180 
                                -----------------------  -------------------  ----------------  ------------------ 
 Position of 
  previous notification 
  (if 
  applicable) 
                                -----------------------  -------------------  ----------------  ------------------ 
 
 
 
 8. Notified details of the resulting situation on the date on which 
  the threshold was crossed or reached 
 A: Voting rights attached to shares 
 Class/type of      Number of voting rights                      % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                          Direct                Indirect                      Direct                       Indirect 
                    (Art 9 of Directive   (Art 10 of Directive          (Art 9 of Directive          (Art 10 of Directive 
                       2004/109/EC)           2004/109/EC)             2004/109/EC) (DTR5.1)             2004/109/EC) 
                         (DTR5.1)              (DTR5.2.1)                                                 (DTR5.2.1) 
                                         --------------------- 
   GB0031030819                                26,621,969                                                   5.01% 
                   --------------------  ---------------------  ----------------------------------  --------------------- 
 
 
 SUBTOTAL 8. A                      26,621,969                                            5.01% 
                   -------------------------------------------  --------------------------------------------------------- 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of            Expiration            Exercise/              Number of voting                    % of voting 
  financial          date                  Conversion Period      rights that may                     rights 
  instrument                                                      be acquired if 
                                                                  the instrument 
                                                                  is 
                                                                  exercised/converted. 
                   --------------------  ---------------------  ----------------------------------  --------------------- 
 
 
 
                                          SUBTOTAL 8. B 1 
                                         ---------------------  ----------------------------------  --------------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of           Expiration             Exercise/              Physical or      Number of          % of voting 
  financial         date                  Conversion              cash             voting rights      rights 
  instrument                              Period                  settlement 
                  ---------------------  ---------------------  ---------------  ----------------- 
 
 
 
                                                                 SUBTOTAL 8.B.2 
                                                                ---------------  ----------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                          X 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer 
 Full chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity (please add additional 
  rows as necessary) 
   Name               % of voting rights              % of voting rights         Total of both if 
                        if it equals or                through financial          it equals or is 
                      is higher than the               instruments if it          higher than the 
                     notifiable threshold             equals or is higher       notifiable threshold 
                                                      than the notifiable 
                                                           threshold 
            -------------------------------------  ------------------------  ------------------------ 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                                   -------------------------------------------------- 
 The number and % of voting rights 
  held 
                                                   -------------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                                   -------------------------------------------------- 
 
 11. Additional information 
 
 
 
 
 Place of completion   Amsterdam 
 Date of completion    23 September 2020 
                      ------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLEADNSALLEEFA

(END) Dow Jones Newswires

September 25, 2020 09:46 ET (13:46 GMT)

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart
ADVFN Advertorial
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201029 02:46:26